Cipla Limited has secured the 45th position in the WCRC Intelligence India's Most Powerful Brands 2024-25 ranking.
Cipla's brand story is intertwined with one of the most significant moments in global public health — when Dr. Yusuf Hamied offered AIDS triple-therapy drugs at $1 a day.
This legacy of accessibility continues to define the Cipla brand. The company's respiratory care portfolio has made quality treatment affordable for millions.
"Cipla's brand is built on moral authority — a rare asset in the pharmaceutical industry," noted the WCRC Intelligence Unit.
The company's investment in digital health technologies is modernizing the brand for a new generation.
Cipla's expansion into specialty therapeutics and biosimilars represents strategic brand evolution.
